Page last updated: 2024-09-04

ezetimibe and Neurotic Disorders

ezetimibe has been researched along with Neurotic Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alfadhel, M; Alghamdi, F; Alghamdi, J; Alghamdi, S; Matou-Nasri, S; Padmanabhan, S	1

Other Studies

1 other study(ies) available for ezetimibe and Neurotic Disorders

Article	Year
Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study. The international journal of neuropsychopharmacology, 2018, 12-01, Volume: 21, Issue:12 Topics: Depressive Disorder; Ezetimibe; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Membrane Proteins; Membrane Transport Proteins; Mendelian Randomization Analysis; Neurotic Disorders; PCSK9 Inhibitors; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Sleep Initiation and Maintenance Disorders	2018

Article

Year

Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study.

The international journal of neuropsychopharmacology, 2018, 12-01, Volume: 21, Issue:12

Topics: Depressive Disorder; Ezetimibe; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Membrane Proteins; Membrane Transport Proteins; Mendelian Randomization Analysis; Neurotic Disorders; PCSK9 Inhibitors; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Sleep Initiation and Maintenance Disorders

2018